A+C, On the finance end RSPI has been tough to figure out. In the previous 10-Q the cash level was $53 K on Dec 31 2015, then down to $6 K on March 31, and now it's back to $53 K.
Obviously they've been getting funding from somewhere, but it would probably take a CPA to figure it out. It appears management has been at least partially self-funding the company, and they also raised some modest amounts over the past year in convertible financings. There was also a lot of restructuring of options and warrants, so the company may have gotten modest cash infusions from that(?).
Not sure, but bottom line they somehow managed to get the CX-1739 trial done. I'll feel better though once they get a few million in the bank. Current management has a strong backround in finance, so I'm figuring they'll have a recapitalization as part of the reverse split process.
News 
Market Data 
Discover 
